Brain Aneurysm Foundation
Medtronic Inc
NIH
Medical College of Wisconsin
See- Mode Technologies
University of Chicago
University at Buffalo
NIA
Trustees of Dartmouth College
MicroVention Inc
Chiesi America Inc
Current and Past Grants
NIH Grant 1 R01 AG065238-01: Neurocognitive Impairment Assessment in Symptomatic Carotid Occlusion Recanalized Endovascularly: NIA SCORE
NIH Grant 1 R01 AG068848-01A1: The Use of Deferiprone to Improve Subarachnoid Hemorrhage Cognitive Outcome: U-DISCO
NIH Grant 1 R01 NS107293-01A1: 15-PGDH as a better therapeutic target than aspirin in decreasing risk of intracranial aneurysm rupture in men and women equally
NIH Grant R2017060108: Mechanisms of Effect of Aspirin on Cerebral Aneurysms in Mice
Current and Past Sponsored Trials
Chiesi USA, Inc.: A Phase 1/2a Exploratory Clinical Trial to Evaluate the Safety of Oral Deferiprone (21 days) Including Its Effect on Decreasing the Content of Iron in Subjects with Aneurysmal Subarachnoid Hemorrhage (aSAH)
Medicure Inc.: iSPASM Induced Suppression of Platelets Activity in Aneurysmal SAH Management
Advanced Endovascular Therapeutics: Evaluation of a Nanometer-Scale Hemocompatible and Antithrombotic Coating Technology for Commercially Available Intracranial Stents and Flow Diverters
Brain Aneurysm Foundation: The Role of Inflammation and Myeloperoxidase in Cerebral Aneurysm Formation and Rupture